Breaking News Instant updates and real-time market news.

ADMA

ADMA Biologics

14:54
06/16/17
06/16
14:54
06/16/17
14:54

Biotest reports 25% stake in ADMA Biologics

Biotest said that the purpose of the transaction is so it can acquire a substantial voting and equity interest in ADMA in exchange for the assets described herein and to enter into certain other agreements between the parties.

ADMA ADMA Biologics

01/23/17
MAXM
01/23/17
UPGRADE
Target $13
MAXM
Buy
ADMA Biologics upgraded on RI-002 manufacturing purchase at Maxim
As previously reported, Maxim upgraded ADMA Biologics to Buy from Hold and established a $13 price target. Analyst Jason Kolbert said ADMA announced it will acquire Biotest's 126,000 square foot immunoglobulin manufacturing assets where RI-002 is manufactured, putting it in a position to address the most complex issues related to manufacturing compliance. Kolbert said ADMA is now better positioned to drive changes needed to re-submit the BLA and integrate manufacturing costs that should increase margins.
01/23/17
MAXM
01/23/17
UPGRADE
MAXM
Buy
ADMA Biologics upgraded to Buy from Hold at Maxim
08/01/16
MAXM
08/01/16
DOWNGRADE
MAXM
Hold
ADMA Biologics downgraded to Hold from Buy at Maxim
08/01/16
RAJA
08/01/16
DOWNGRADE
RAJA
Market Perform
ADMA Biologics downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst Reni Benjamin downgraded ADMA Biologics to Market Perform from Strong Buy following the complete response letter, or CRL, issued by the FDA regarding the company's Biologics License Application for RI-002 for the treatment of primary humoral immunodeficiency disease. The analyst continues to believe RI-002 is approvable given that the CRL was solely related to outstanding inspection issues and deficiencies at ADMA's third-party contract manufacturers but said uncertainty surrounding the timing of the resubmission and review remain the key issue.

TODAY'S FREE FLY STORIES

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

, NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Technical Analysis
Technical Take: NeuroMetrix up sharply, GlaxoSmithKline strategic collaboration »

NeuroMetrix (NURO) was…

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

MOBL

MobileIron

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
MobileIron initiated  »

MobileIron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JEC

Jacobs Engineering

$69.42

-0.14 (-0.20%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Hot Stocks
Jacobs wins engineering services agreement from Carcross/Tagish Energy »

Jacobs Engineering Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

07:50
01/17/18
01/17
07:50
01/17/18
07:50
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico,…

GM

General Motors

$44.19

0.12 (0.27%)

07:49
01/17/18
01/17
07:49
01/17/18
07:49
Periodicals
GM, DHL use Chinese plant to handle flow of parts, Reuters reports »

DHL employees have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

EGAN

eGain

$5.35

-0.35 (-6.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Initiation
eGain initiated  »

eGain initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$221.53

0.3 (0.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Recommendations
Netflix analyst commentary  »

Netflix checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 30

    Jan

XRAY

Dentsply Sirona

$65.65

-0.14 (-0.21%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Dentsply Sirona adds three new board members »

Dentsply Sirona has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
01/17/18
01/17
07:47
01/17/18
07:47
General news
Futures suggest rebound from yesterday's dip »

Stock futures are higher…

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Pearson: U.S. tax reform to result in one-off deferred tax charge in 2017 »

Pearson says, "Our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Hot Stocks
Pearson sees FY18 adjusted operating profit GBP520M-GBP560M »

Pearson says, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$21.49

-0.83 (-3.72%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Initiation
Boingo Wireless initiated  »

Boingo Wireless initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Earnings
Pearson sees FY adjusted EPS above 49p-52p guidance range »

Adjusted earnings per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Technical Analysis
Technical Take: Adient falls sharply in pre-market, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

ESPR

Esperion

$71.91

-1.35 (-1.84%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Recommendations
Esperion analyst commentary  »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$68.78

-0.48 (-0.69%)

07:44
01/17/18
01/17
07:44
01/17/18
07:44
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$7.60

-0.16 (-2.06%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Downgrade
Norsk Hydro rating change  »

Norsk Hydro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$55.44

-0.15 (-0.27%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Earnings
Fastenal reports Q4 EPS 45c ex-tax benefit, consensus 45c »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Recommendations
Juno Therapeutics, Celgene analyst commentary  »

Juno Therapeutics price…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Goldman CEO: Global economy poised to accelerate, tax reform providing tailwinds »

"Last year, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

ONTX

Onconova

$1.74

-0.0901 (-4.92%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Onconova increases sample size in Phase 3 INSPIRE pivotal trial in MDS »

Onconova is moving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$19.74

-0.62 (-3.05%)

07:41
01/17/18
01/17
07:41
01/17/18
07:41
Technical Analysis
Technical Take: Halozyme drops in pre-market »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

07:41
01/17/18
01/17
07:41
01/17/18
07:41
Conference/Events
UBS oil services analyst holds an analyst/industry conference call »

Oil Services Analyst Wong…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.